Singapore Neokidney Moves Closer
Nextkidney BV, which makes the sorbent-based home hemodialysis Neokidney, has signed a deal to buy Dialyss Pte. Ltd. as it gears up for commercialization. Next up: a clinical trial in Singapore, then a European multicenter trial, with CE mark submission in 2023.
Read the full article » | Posted 02-15-2022
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025